Overactive bladder-18 years - Part I
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | https://repositorio.unifesp.br/handle/11600/57828 http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0365 |
Resumo: | Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals - including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years. |
id |
UFSP_84036c0270c2be2e744908d829056332 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br:11600/57828 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Truzzi, Jose Carlos [UNIFESP]Gomes, Cristiano MendesBezerra, Carlos A.Plata, Ivan MauricioCampos, JoseGarrido, Gustavo LuisAlmeida, Fernando G. [UNIFESP]Averbeck, Marcio AugustoFornari, AlexandreSalazar, AnibalDell'Oro, ArturoCintra, CaioRicetto Sacomani, Carlos AlbertoTapia, Juan PabloBrambila, EduardoLongo, Emilio MiguelRocha, Flavio TrigoCoutinho, FranciscoFavre, GabrielGarcia, Jose AntonioCastano, JuanReyes, MiguelLeyton, Rodrigo EugenioFerreira, Ruiter SilvaDuran, SergioLopez, VandaReges, Ricardo2020-08-21T16:59:59Z2020-08-21T16:59:59Z2016International Braz J Urol. Rio De Janeiro, v. 42, n. 2, p. 188-198, 2016.1677-5538https://repositorio.unifesp.br/handle/11600/57828http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0365S1677-55382016000200188-en.pdfS1677-5538201600020018810.1590/S1677-5538.IBJU.2015.0365WOS:000375604900005Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals - including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years.Univ Fed Sao Paulo, EPM, Rua Dr Oscar Monteiro Barros 617-141, BR-05641010 Sao Paulo, SP, BrazilUniv Sao Paulo, Dept Urol, BR-05508 Sao Paulo, SP, BrazilFac Med ABC, Dept Urol, Sao Paulo, SP, BrazilUniv Los Andes, Dept Urol, Bogota, ColombiaEscuela Med, Dept Urol, Mexico City, DF, MexicoHosp Clin Jose San Martin, Catedra Urol, Buenos Aires, DF, ArgentinaMae de Deus Ctr Hosp, Dept Urol, Porto Alegre, RS, BrazilUniv Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, BrazilAC Camargo Hosp, Dept Urol, Sao Paulo, BrazilHosp Clin Fuerza Area Chile, Santiago, ChileInst Mexicano Seguro Social, Mexico City, DF, MexicoHosp Souza Aguiar, Dept Urol, Rio De Janeiro, RJ, BrazilComplejo Med Policial Churruca Visca, Serv Urol, Buenos Aires, DF, ArgentinaCtr Policlin Valencia Vina, Valencia, VenezuelaHosp Pablo Tobon Uribe, Medellin, ColombiaClin Indisa, Serv Urol, Providencia, ChileCtr Reabilitacao & Readaptacao Dr Henriqe Santill, Goiania, Go, BrazilHosp Univ Caracas, Serv Urol, Caracas, VenezuelaUniv Fed Ceara, Div Urol, Fortaleza, Ceara, BrazilUniv Fed Sao Paulo, EPM, Rua Dr Oscar Monteiro Barros 617-141, BR-05641010 Sao Paulo, SP, BrazilWeb of Science188-198engBrazilian Soc UrolInternational Braz J UrolOveractive BladderMuscarinic AntagonistsBeta-adrenergic agonistsBotulinum ToxinSacral neuromodulationUrodynamicsOveractive bladder-18 years - Part Iinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleRio De Janeiro422info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALS1677-55382016000200188-en.pdfapplication/pdf110532${dspace.ui.url}/bitstream/11600/57828/1/S1677-55382016000200188-en.pdfecb07c032bc7df173150023822e7bee9MD51open accessTEXTS1677-55382016000200188-en.pdf.txtS1677-55382016000200188-en.pdf.txtExtracted texttext/plain50353${dspace.ui.url}/bitstream/11600/57828/2/S1677-55382016000200188-en.pdf.txt17bd162aaae9509750e9e9d9e730ae27MD52open accessTHUMBNAILS1677-55382016000200188-en.pdf.jpgS1677-55382016000200188-en.pdf.jpgIM Thumbnailimage/jpeg6343${dspace.ui.url}/bitstream/11600/57828/4/S1677-55382016000200188-en.pdf.jpg523b8be3b842dd0c72c63a8593f5c6c3MD54open access11600/578282022-07-31 19:53:57.737open accessoai:repositorio.unifesp.br:11600/57828Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652022-07-31T22:53:57Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.en.fl_str_mv |
Overactive bladder-18 years - Part I |
title |
Overactive bladder-18 years - Part I |
spellingShingle |
Overactive bladder-18 years - Part I Truzzi, Jose Carlos [UNIFESP] Overactive Bladder Muscarinic Antagonists Beta-adrenergic agonists Botulinum Toxin Sacral neuromodulation Urodynamics |
title_short |
Overactive bladder-18 years - Part I |
title_full |
Overactive bladder-18 years - Part I |
title_fullStr |
Overactive bladder-18 years - Part I |
title_full_unstemmed |
Overactive bladder-18 years - Part I |
title_sort |
Overactive bladder-18 years - Part I |
author |
Truzzi, Jose Carlos [UNIFESP] |
author_facet |
Truzzi, Jose Carlos [UNIFESP] Gomes, Cristiano Mendes Bezerra, Carlos A. Plata, Ivan Mauricio Campos, Jose Garrido, Gustavo Luis Almeida, Fernando G. [UNIFESP] Averbeck, Marcio Augusto Fornari, Alexandre Salazar, Anibal Dell'Oro, Arturo Cintra, Caio Ricetto Sacomani, Carlos Alberto Tapia, Juan Pablo Brambila, Eduardo Longo, Emilio Miguel Rocha, Flavio Trigo Coutinho, Francisco Favre, Gabriel Garcia, Jose Antonio Castano, Juan Reyes, Miguel Leyton, Rodrigo Eugenio Ferreira, Ruiter Silva Duran, Sergio Lopez, Vanda Reges, Ricardo |
author_role |
author |
author2 |
Gomes, Cristiano Mendes Bezerra, Carlos A. Plata, Ivan Mauricio Campos, Jose Garrido, Gustavo Luis Almeida, Fernando G. [UNIFESP] Averbeck, Marcio Augusto Fornari, Alexandre Salazar, Anibal Dell'Oro, Arturo Cintra, Caio Ricetto Sacomani, Carlos Alberto Tapia, Juan Pablo Brambila, Eduardo Longo, Emilio Miguel Rocha, Flavio Trigo Coutinho, Francisco Favre, Gabriel Garcia, Jose Antonio Castano, Juan Reyes, Miguel Leyton, Rodrigo Eugenio Ferreira, Ruiter Silva Duran, Sergio Lopez, Vanda Reges, Ricardo |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Truzzi, Jose Carlos [UNIFESP] Gomes, Cristiano Mendes Bezerra, Carlos A. Plata, Ivan Mauricio Campos, Jose Garrido, Gustavo Luis Almeida, Fernando G. [UNIFESP] Averbeck, Marcio Augusto Fornari, Alexandre Salazar, Anibal Dell'Oro, Arturo Cintra, Caio Ricetto Sacomani, Carlos Alberto Tapia, Juan Pablo Brambila, Eduardo Longo, Emilio Miguel Rocha, Flavio Trigo Coutinho, Francisco Favre, Gabriel Garcia, Jose Antonio Castano, Juan Reyes, Miguel Leyton, Rodrigo Eugenio Ferreira, Ruiter Silva Duran, Sergio Lopez, Vanda Reges, Ricardo |
dc.subject.eng.fl_str_mv |
Overactive Bladder Muscarinic Antagonists Beta-adrenergic agonists Botulinum Toxin Sacral neuromodulation Urodynamics |
topic |
Overactive Bladder Muscarinic Antagonists Beta-adrenergic agonists Botulinum Toxin Sacral neuromodulation Urodynamics |
description |
Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals - including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years. |
publishDate |
2016 |
dc.date.issued.fl_str_mv |
2016 |
dc.date.accessioned.fl_str_mv |
2020-08-21T16:59:59Z |
dc.date.available.fl_str_mv |
2020-08-21T16:59:59Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
International Braz J Urol. Rio De Janeiro, v. 42, n. 2, p. 188-198, 2016. |
dc.identifier.uri.fl_str_mv |
https://repositorio.unifesp.br/handle/11600/57828 http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0365 |
dc.identifier.issn.none.fl_str_mv |
1677-5538 |
dc.identifier.file.none.fl_str_mv |
S1677-55382016000200188-en.pdf |
dc.identifier.scielo.none.fl_str_mv |
S1677-55382016000200188 |
dc.identifier.doi.none.fl_str_mv |
10.1590/S1677-5538.IBJU.2015.0365 |
dc.identifier.wos.none.fl_str_mv |
WOS:000375604900005 |
identifier_str_mv |
International Braz J Urol. Rio De Janeiro, v. 42, n. 2, p. 188-198, 2016. 1677-5538 S1677-55382016000200188-en.pdf S1677-55382016000200188 10.1590/S1677-5538.IBJU.2015.0365 WOS:000375604900005 |
url |
https://repositorio.unifesp.br/handle/11600/57828 http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0365 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.none.fl_str_mv |
International Braz J Urol |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
188-198 |
dc.coverage.none.fl_str_mv |
Rio De Janeiro |
dc.publisher.none.fl_str_mv |
Brazilian Soc Urol |
publisher.none.fl_str_mv |
Brazilian Soc Urol |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
bitstream.url.fl_str_mv |
${dspace.ui.url}/bitstream/11600/57828/1/S1677-55382016000200188-en.pdf ${dspace.ui.url}/bitstream/11600/57828/2/S1677-55382016000200188-en.pdf.txt ${dspace.ui.url}/bitstream/11600/57828/4/S1677-55382016000200188-en.pdf.jpg |
bitstream.checksum.fl_str_mv |
ecb07c032bc7df173150023822e7bee9 17bd162aaae9509750e9e9d9e730ae27 523b8be3b842dd0c72c63a8593f5c6c3 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
|
_version_ |
1802764117380956160 |